StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note published on Sunday morning. The firm issued a sell rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $3.00 price target on shares of Moleculin Biotech in a research note on Thursday, December 14th. […]
STAT Inhibitors Clinical Trial Analysis: Delveinsight Evaluates A Robust Pipeline As 22+ Influential Pharma Players To Set Foot In The Domain menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Moleculin Biotech, Inc. (NASDAQ:MBRX – Get Free Report) CFO Jonathan P. Foster bought 28,986 shares of the business’s stock in a transaction on Tuesday, December 26th. The shares were purchased at an average cost of $0.69 per share, with a total value of $20,000.34. Following the transaction, the chief financial officer now owns 80,556 shares […]
StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report issued on Saturday morning. The brokerage issued a sell rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $3.00 target price on shares of Moleculin Biotech in a report on Thursday, December 14th. Get Our […]
Moleculin Announces Pricing of $4 5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.